Amylyx Pharmaceuticals Inc XNAS: AMLX

Amylyx Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Amylyx Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Amylyx Pharmaceuticals Inc
Rating: 1.297694375
Author: Trendlyne DVM scores

Momentum Trap

Download real time

3.73 0.08 (2.19%)

48.69% Fall from 52W High

366.2K XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

18.3 / 100

Technically Moderately Bullish

63.3 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

8

1Yr Price target upside is 114%

5 analysts

Amylyx Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Amylyx Pharmaceuticals Inc FAQ

How is Amylyx Pharmaceuticals Inc today?

Amylyx Pharmaceuticals Inc today is trading in the green, and is up by 2.19% at 3.73.

How has Amylyx Pharmaceuticals Inc performed historically?

Amylyx Pharmaceuticals Inc is currently trading up 2.19% on an intraday basis. In the past week the stock fell -4.60%. stock has been down -5.81% in the past quarter and rose 27.30% in the past year. You can view this in the overview section.